New York State Common Retirement Fund
BOLT icon

New York State Common Retirement Fund’s Bolt Biotherapeutics BOLT Stock Holding History

New York State Common Retirement Fund’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9
Closed – – 3287
2022
Q2 		$0 Sell
9
-510
-98% -$19.8K ﹤0.01% 3479
2022
Q1 		$28K Hold
519
– – ﹤0.01% 3258
2021
Q4 		$51K Buy
519
+293
+130% +$55.6K ﹤0.01% 3215
2021
Q3 		$57K Sell
226
-349
-61% -$98.6K ﹤0.01% 3228
2021
Q2 		$178K Buy
575
+165
+40% +$67K ﹤0.01% 3087
2021
Q1 		$270K Buy
+410
New +$267K ﹤0.01% 2717

Other funds holding BOLT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

New York State Common Retirement Fund's BOLT Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Bolt Biotherapeutics (BOLT) in Q3 2022, closing a stake of 9 shares.

New York State Common Retirement Fund first reported a position in BOLT in Q1 2021 and held it in 6 quarters. The position peaked at $270K in Q1 2021. 56 funds tracked by Wall St. Rank hold BOLT as of Q3 2022.

  • New York State Common Retirement Fund reported no remaining Bolt Biotherapeutics position as of Q3 2022 after selling out during the quarter.
  • New York State Common Retirement Fund sold 9 Bolt Biotherapeutics shares in Q3 2022.
  • New York State Common Retirement Fund first reported a position in Bolt Biotherapeutics in Q1 2021 and held it in 6 quarters.
  • New York State Common Retirement Fund's Bolt Biotherapeutics position peaked at $270K in Q1 2021.
  • 56 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.